ClinicalTrials.gg
CompletedNCT07869771Updated Oct 13, 2026

The Effect of Pulsed Radiofrequency Ablation of the Genicular Nerve on Pain, Balance, and Proprioception in Patients With Chronic Knee Osteoarthritis

An interventional study of Genicular nerve block via radiofrequency ablation in Knee Osteoarthritis (OA), Genicular Nerves Block and Radiofrequency Ablation, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2025, registered Oct 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Not applicable
Ages
45 Years to 80 Years
Sex
All
01

Study summary

Determination of the effect of ultrasound-guided pulsed radiofrequency applied to the genicular nerve on pain, balance, and proprioception in patients with chronic knee osteoarthritis

Read the detailed description

Surgical and non-surgical methods are used to treat knee osteoarthritis. Non-surgical treatments include patient education, self-management strategies, strengthening exercises, weight control, physical therapy, orthosis use, oral analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), steroids, hyaluronic acid, platelet-rich plasma (PRP) injections, prolotherapy, stem cell therapy, and genicular nerve blocks. All of these aim to reduce pain, improve function, and delay the need for surgery.

The genicular nerve block is a recently developed treatment option for knee osteoarthritis that targets three sensory nerves of the knee-the superior lateral, superior medial, and inferior medial genicular nerves-to block pain transmission to the central nervous system. Unlike alternatives such as intra-articular treatments and surgery, the block procedure is performed outside the knee joint. Genicular nerve blockade via radiofrequency ablation appears to be an emerging alternative for patients for whom conservative and surgical treatments have proven insufficient. Radiofrequency ablation of the genicular nerve provides temporary relief for symptomatic knee osteoarthritis, as it does not eliminate the potential for peripheral nerve regrowth and regeneration, and thus the recurrence of pain. Previous studies have also reported accidental falls in patients following genicular nerve radiofrequency ablation procedures. These findings have raised concerns that the genicular nerve radiofrequency ablation procedure may alter proprioception and impair balance. This study was conducted because there are a limited number of studies investigating the effects of genicular nerve block on pain and function in patients with chronic knee osteoarthritis.

02

Conditions studied

  • Knee Osteoarthritis (OA)
  • Genicular Nerves Block
  • Radiofrequency Ablation

Keywords

  • radiofrequency ablation
  • genıcular nerve
  • nerve block
  • knee pain
  • balance
  • proprioception
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's enrollment of 28 is below the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 437 studies on the registry; 109 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 45-80 years
  • Patients diagnosed with knee osteoarthritis according to American College of Rheumatology criteria and presenting with Kellgren-Lawrence grade 2 or 3 radiological osteoarthritis
  • Intact cognitive function
  • INR ≤1.2
  • Willingness to participate in the study and sign informed consent forms

Exclusion criteria

Exclusion criteria:

  • Presence of neurological and/or vestibular disease causing balance impairment
  • Physical therapy for knee osteoarthritis within the last 6 months
  • Glucocorticoid or hyaluronic acid injection within the last 6 months
  • Use of oral glucosamine
  • History of knee surgery
  • Existing neurological or mental disorders
  • History of pacemaker use
  • Local infections or sepsis
  • Progressive neurological deficit
  • Oncological diseases
  • History of systemic inflammatory diseases such as rheumatoid arthritis
  • Clinically significant structural abnormalities-in addition to osteoarthritis-that affect movement and knee function and could cause chronic knee pain
  • Bleeding diathesis or INR >1.2
  • Uncontrolled diabetes or other serious internal comorbidities
  • Allergy to the medication or materials used
  • Pregnancy
  • Lack of cooperation
  • Refusal to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Patients diagnosed with chronic knee osteoarthritis

    Patients aged 45-80 years diagnosed with chronic knee osteoarthritis according to American College of Rheumatology criteria and presenting with Kellgren-Lawrence grade 2 or 3 radiological osteoarthritis

    Other: Genicular nerve block via radiofrequency ablation

Interventions

  • OtherGenicular nerve block via radiofrequency ablation

    The aim is to determine the effects on pain, balance, and proprioception following ultrasound-guided pulsed genicular nerve radiofrequency ablation in patients with chronic knee osteoarthritis.

    Also known as: Genicular nerve block, radiofrequency ablation

06

What researchers measure

Primary outcomes

  1. knee pain

    Zero is equivalent to no pain, and 10 indicates the worst possible pain.

    Time frame: first month and third month

Secondary outcomes

  1. balance

    The HUR SmartBalance BTG4 system will be used to measure both static and dynamic postural balance. An increase in the equilibrium value in percentage terms will indicate an improvement.

    Time frame: first and third month

  2. proprioception

    The Biodex System 3 (Biodex Medical Systems, Shirley, NY, USA) isokinetic dynamometer will be used to measure proprioception. Patients' proprioceptive sense will be assessed at 15 and 45 degrees. Indicating how closely the patient-with eyes closed-can perceive the 15-degree and 45-degree angles will demonstrate the change in proprioception.

    Time frame: first and third month

07

Study locations

1 site
  • Ankara Bilkent City Hospital
    Ankara, Turkey (Türkiye)
08

References and documents

Publications

  • 1- Fibel KH, Hillstrom HJ, Halpern BC. Modern management of knee osteoarthritis. World J Clinic Cases. 2015; 3 :89-101. doi: 10.12998/wjcc.v3.i2.89. 2- Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. Global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014; 73:1323-1330. doi: 10.1136/annrheumdis-2013-204763. 3- van Doormaal MCM, Meerhoff GA, Vliet Vlieland TPM, Peter WF. Clinical practice guideline for physical therapy in patients with hip or knee osteoarthritis. Musculoskeletal Care. 2020; 18:575-595. doi: 10.1002/msc.1492. 4- Kesikburun S, Yaşar E, Uran A, Adıgüzel E, Yılmaz B. Ultrasound-guided genicular nerve pulsed radiofrequency therapy for painful knee osteoarthritis: a preliminary report. Pain Phys. 2016; 19 :E751-759. doi: 10.36076/ppj/2019.19.E751. 5- Deyle GD, Allison SC, Matekel RL, et al. Effectiveness of physical therapy treatment for knee osteoarthritis: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Physics Sweat. 2005; 85:1301-1317. doi: 10.1093/ptj/85.12.1301. 6- van Doormaal MCM, Meerhoff GA, Vliet Vlieland TPM, Peter WF. Clinical practice guideline for physical therapy in patients with hip or knee osteoarthritis. Musculoskeletal Care. 2020; 18:575-595. doi: 10.1002/msc.1492. 7- Dantas LO, Salvini TF, McAlindon TE. Knee osteoarthritis: basic treatments and implications for physical therapy. Braz J Phys Ther. 2021; 25 :135-146. doi: 10.1016/j.bjpt.2020.08.004. 8- Kim DH, Lee MS, Lee S, Yoon SH, Shin JW, Choi SS. Prospective study of the effectiveness of ultrasound and fluoroscopy-guided genicular nerve block for chronic knee osteoarthritis randomized comparison. Pain Phys. 2019; 22:139-146. 9- Crawford DC, Miller LE, Block JE. Conservative management of symptomatic knee osteoarthritis: a flawed strategy? Orthopedic Rev (Pavia). 2013; 5 ( 1 ):e2.

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07869771
Responsible party
Seher KALIÇ (specialist of physical therapy and rehabilitation, Ankara City Hospital Bilkent) — Principal investigator
First posted
Oct 13, 2026
Start date
Jan 24, 2025
Primary completion
Jun 30, 2026
Completion
Sep 30, 2026
Last update
Oct 13, 2026

Study contacts

seher kalic
principal investigator · Ankara City Hospital Bilkent
huma boluk senlikci
principal investigator · Ankara City Hospital Bilkent
emre adiguzel
study director · Ankara City Hospital Bilkent
ayse m ata
principal investigator · Ankara City Hospital Bilkent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion